| 000 | 01738 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517171232.0 | ||
| 264 | 0 | _c20180507 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a2769-819X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFahey, James R | |
| 245 | 0 | 0 |
_aAntibiotic-associated Manipulation of the Gut Microbiota and Phenotypic Restoration in NOD Mice. _h[electronic resource] |
| 260 |
_bComparative medicine _cAug 2017 |
||
| 300 |
_a335-343 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAmpicillin _xpharmacology |
| 650 | 0 | 4 |
_aAnimal Husbandry _xmethods |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aDecontamination _xmethods |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xgenetics |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aEnvironmental Monitoring _xmethods |
| 650 | 0 | 4 |
_aFeces _xmicrobiology |
| 650 | 0 | 4 |
_aGastrointestinal Microbiome _xdrug effects |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 |
_aGram-Positive Bacteria _xclassification |
| 650 | 0 | 4 |
_aGram-Positive Bacterial Infections _xdrug therapy |
| 650 | 0 | 4 | _aHost-Pathogen Interactions |
| 650 | 0 | 4 |
_aIntestines _xdrug effects |
| 650 | 0 | 4 | _aMice, Inbred NOD |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aTh1 Cells _ximmunology |
| 650 | 0 | 4 |
_aTh17 Cells _ximmunology |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aLyons, Bonnie L | |
| 700 | 1 | _aOlekszak, Haiyan L | |
| 700 | 1 | _aMourino, Anthony J | |
| 700 | 1 | _aRatiu, Jeremy J | |
| 700 | 1 | _aRacine, Jeremy J | |
| 700 | 1 | _aChapman, Harold D | |
| 700 | 1 | _aSerreze, David V | |
| 700 | 1 | _aBaker, Dina L | |
| 700 | 1 | _aHendrix, N Ken | |
| 773 | 0 |
_tComparative medicine _gvol. 67 _gno. 4 _gp. 335-343 |
|
| 999 |
_c27487631 _d27487631 |
||